Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2024 | FY2025 |
|---|---|---|
| Revenue | $11.8M | $13.6M |
| Revenue growth | — | 15.3% |
| Gross profit | $6.38M | $7.17M |
| Gross margin | 54.2% | 52.9% |
| Operating income | -$19.9M | -$25.5M |
| Operating margin | -169.4% | -188.3% |
| Net income | -$19.9M | -$25.3M |
| Net margin | -169.3% | -186.8% |
| EPS (diluted) | -$9.85 | -$1.03 |
| Fiscal year | FY2024 | FY2025 |
|---|---|---|
| Operating cash flow | -$20.1M | -$22.9M |
| Capital expenditures | $153K | $90.0K |
| Free cash flow | -$20.2M | -$23.0M |
| Fiscal year | FY2024 | FY2025 |
|---|---|---|
| Total assets | $16.8M | $18.2M |
| Total liabilities | $2.69M | $4.90M |
| Shareholders' equity | -$130M | $13.3M |
| Retained earnings | -$130M | -$156M |
| Shares (wtd avg diluted) | 2.02M | 24.6M |
Every figure is extracted from CapsoVision, Inc’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.